VLACHOVSKÝ, Robert, Robert STAFFA and Zdeněk GREGOR. Long-term patency of a RaK collagen vascular prosthesis - single centre results during a 10 year follow-up. Bratislava Medical Journal - Bratislavské lekárske listy. BRATISLAVA: Univerzita Komenského, 2013, vol. 114, No 1, p. 15-18. ISSN 0006-9248. doi:10.4149/BLL_2013_004.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Long-term patency of a RaK collagen vascular prosthesis - single centre results during a 10 year follow-up
Authors VLACHOVSKÝ, Robert (203 Czech Republic, guarantor, belonging to the institution), Robert STAFFA (203 Czech Republic, belonging to the institution) and Zdeněk GREGOR (203 Czech Republic, belonging to the institution).
Edition Bratislava Medical Journal - Bratislavské lekárske listy, BRATISLAVA, Univerzita Komenského, 2013, 0006-9248.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30000 3. Medical and Health Sciences
Country of publisher Slovakia
Confidentiality degree is not subject to a state or trade secret
Impact factor Impact factor: 0.446
RIV identification code RIV/00216224:14110/13:00070189
Organization unit Faculty of Medicine
Doi http://dx.doi.org/10.4149/BLL_2013_004
UT WoS 000313776200004
Keywords in English patency; long-term; prosthesis; vascular
Tags International impact, Reviewed
Changed by Changed by: Ing. Mgr. Věra Pospíšilíková, učo 9005. Changed: 22/11/2013 16:25.
The aim of this retrospective study was to evaluate the results of vascular,operations based on the RaK prostheses, with a particular attention paid to their long-term patency. The study included 105 patients who were operated on in the period from 1992 to 1996. Vascular surgery was performed in the aortofemoral area and the underlying diagnoses were Leriche syndrome, asymptomatic abdominal aortic aneurysm, iliac artery stenosis or occlusion and symptomatic abdominal aortic aneurysm. During the mean follow-up time of 96 months (range 28-144), 8 patients (7.6 %) were lost to follow-up and 23 patients (21.9 %) died. At 12, 36, 60 and 120 months after surgery, the prostheses were patent in 99 %, 98 %, 93 % and 89 % of the patients, respectively. It is concluded that the RaK collagen prosthesis is the device of high quality and parameters comparable with the other types of knitted vascular prostheses currently used (Tab. 3, Fig. 4, Ref. 17).
PrintDisplayed: 27/3/2023 11:27